Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.
about
Hearing loss in children with very low birth weight: current review of epidemiology and pathophysiology."Random" gentamicin concentrations do not predict trough levels in neonates receiving once daily fixed dose regimens.Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).Simplified dosing of gentamicin for treatment of sepsis in Bangladeshi neonates.Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study.Extended-interval gentamicin dosing in achieving therapeutic concentrations in malaysian neonatesGentamicin in neonates at risk for sepsis - peak serum concentrations are not necessaryIs a once daily dose of gentamicin safe and effective in the treatment of uti in infants and children?Developing paediatric medicines: identifying the needs and recognizing the challenges.Scientific rationale for study design of community-based simplified antibiotic therapy trials in newborns and young infants with clinically diagnosed severe infections or fast breathing in South Asia and sub-Saharan AfricaSafety and efficacy of simplified antibiotic regimens for outpatient treatment of serious infection in neonates and young infants 0-59 days of age in Bangladesh: design of a randomized controlled trialAntibiotics for the newborn.Comparison of Amikacin Pharmacokinetics in Neonates Following Implementation of a New Dosage Protocol.Aminoglycoside-induced nephrotoxicity in children.The amikacin research program: a stepwise approach to validate dosing regimens in neonates.Cerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates.Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants.Pharmacokinetic approach for optimizing gentamicin use in neonates during the first week of life.Gentamicin trough levels using a simplified extended-interval dosing regimen in preterm and term newborns.Single daily dose aminoglycosides in the neonatal period appear to be effective: but are they safe?Reducing the dosing frequency of aminoglycosides can increase errors.Use of netilmicin once or twice daily in preterm newborns: evaluation of nephrotoxicity by urinary alpha1-microglobulin and retinol binding protein.Optimized antimicrobial dosing strategies: a survey of pediatric hospitals.Pharmacokinetics of gentamicin in newborns with moderate-to-severe hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia.Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: a randomized controlled trial.High-dose gentamicin in newborn infants: is it safe?Infectious complications in the management of gastroschisis
P2860
Q30457383-5EDC5675-8D00-4DA3-A8C0-90B3C64F19EBQ33236907-AF1F5C07-165C-475B-92A5-5D27CB973330Q33753500-ED87E5ED-6AAE-4C81-9BCD-BAF1003C2904Q34083485-35143573-3377-48B1-8114-ABDF497E5ED0Q34399423-9A01542B-0DBB-4906-9E2D-5432970C9589Q35566356-AB71CC16-7308-4217-B5F9-2E6E7EDCD820Q36051172-41846A1C-709D-4338-985C-7D47A1AD5809Q36917494-E871CE4F-92F5-4CE7-BE45-018CB69851A3Q36921705-A7CE6059-827A-4F52-8B76-CBB376AF0B04Q37271754-6ABBF6AD-7117-49E6-8CB5-FFCB414AAF3EQ37272780-3528355E-88C5-4360-9E99-E176DBFAA1F1Q37589521-019FB706-EE05-4CA2-9746-DE8FBC24193CQ38740603-F8D7E602-0F00-4563-B6D5-CF2E706C87B0Q38795059-60C0690C-7C7B-47A6-A201-DADAFAD9EF74Q38821699-9934E434-66A0-4297-AAF8-CF72831E3B79Q38899529-E4FA0AB6-E442-4CF3-A459-E7BDB62831BCQ40326667-21A18706-8B29-4488-802A-B0610D2A80BFQ40826687-CF682CC2-CFB5-4ACF-9E9B-3F5E18BA02C0Q41667164-D2B8A226-AE4C-4196-9AB6-3C81905F495BQ43141939-96AB5087-F3E2-467C-A35E-8978CDE43BAFQ43141942-C79173BB-E93D-41F4-BC81-18EB0980B83FQ44634763-14ECABCE-A6BB-4484-B1DF-99F4116D10D3Q44766864-E5218223-9898-44B0-91C4-449D2FED35BDQ45822404-CAE74EFA-48A2-40DB-85FD-A82B61CA950EQ46316950-846C4B40-8A50-4C09-8033-0CF15C14A2CEQ50356292-53FF3BA9-FB2B-4287-A52F-BAB6D8ACF2D6Q58812638-95412A2E-0879-423B-B7A5-157F8D934E24
P2860
Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Aminoglycoside extended interv ...... nd effective: a meta-analysis.
@ast
Aminoglycoside extended interv ...... nd effective: a meta-analysis.
@en
type
label
Aminoglycoside extended interv ...... nd effective: a meta-analysis.
@ast
Aminoglycoside extended interv ...... nd effective: a meta-analysis.
@en
prefLabel
Aminoglycoside extended interv ...... nd effective: a meta-analysis.
@ast
Aminoglycoside extended interv ...... nd effective: a meta-analysis.
@en
P2093
P2860
P356
P1476
Aminoglycoside extended interv ...... nd effective: a meta-analysis.
@en
P2093
P2860
P304
P356
10.1136/ADC.2004.056317
P577
2005-04-27T00:00:00Z